Financials
- Market Capitalization 2.35 B
- Employee 13
- Founded 2006
- CEO Angelos M. Stergiou
- Website www.sellaslifesciences.com
- Headquarter Delaware, United States
- FIGI BBG000VC77H7
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 1872 | AGIO Agios Pharmaceuticals, Inc. - Common Stock | 40.55 USD | -1.65% | +2.35% | +36.58% | -6.55% | 2.41 B USD | ||
| 1885 | NRIX Nurix Therapeutics, Inc. - Common stock | 22.71 USD | -1.52% | -5.65% | +32.81% | +102.59% | 2.36 B USD | ||
| 1888 | TRVI Trevi Therapeutics, Inc. - Common Stock | 16.52 USD | -7.40% | -8.63% | +14.64% | +134.99% | 2.35 B USD | ||
| 1898 | NKTR Nektar Therapeutics - Common Stock | 68.32 USD | -2.90% | -6.60% | +13.36% | -6.76% | 2.31 B USD |
Frequently asked questions about SELLAS Life Sciences Group, Inc. - Common Stock
What is the SELLAS Life Sciences Group, Inc. - Common Stock stock price today?
The current price of SELLAS Life Sciences Group, Inc. - Common Stock (SLS) is 12.62. Over the past 24 hours, the stock has changed by -1.10%. Follow the SLS chart for real-time price dynamics.
What is the stock ticker of SELLAS Life Sciences Group, Inc. - Common Stock?
SELLAS Life Sciences Group, Inc. - Common Stock trades under the ticker SLS. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is SELLAS Life Sciences Group, Inc. - Common Stock stock going up?
SLS has changed by -9.21% over the last week, +59.75% over the last month, and +540.61% over the last year. Review the chart to see whether the current move is part of a broader trend.
Does SELLAS Life Sciences Group, Inc. - Common Stock release financial reports?
Yes. You can track SELLAS Life Sciences Group, Inc. - Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.
What was SELLAS Life Sciences Group, Inc. - Common Stock net income for the last quarter?
SELLAS Life Sciences Group, Inc. - Common Stock reported net income of -8.41 M for the last quarter. The previous quarter showed -7.66 M, which means net income changed by -9.78%.
How many employees does SELLAS Life Sciences Group, Inc. - Common Stock have?
As of the latest available data, SELLAS Life Sciences Group, Inc. - Common Stock has 13 employees. Workforce size can provide additional context about the company's scale and operations.
How can I buy SELLAS Life Sciences Group, Inc. - Common Stock stock?
You can buy SELLAS Life Sciences Group, Inc. - Common Stock (SLS) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in SELLAS Life Sciences Group, Inc. - Common Stock stock?
Investing in SELLAS Life Sciences Group, Inc. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the SLS chart and related analysis on metatrader.com as part of your research.